Regenerative medicines are being given the green light in Japan with safety being the only hurdle. In light of this, there are significantly more new treatments being approved in Japan as compared to the US which has significantly higher requirements.
So although not direct competitors to MSBs product, the quantum of regenerative treatments , coupled with no real efficacy requirement, makes the market penetration significantly slower than what would be usually expected.
- Forums
- ASX - By Stock
- MSB
- Japan as a Funding Source
Japan as a Funding Source, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.020(1.95%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | $1.01 | $2.266M | 2.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 221590 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 171568 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 216283 | 1.005 |
39 | 562463 | 1.000 |
19 | 208840 | 0.995 |
19 | 325707 | 0.990 |
11 | 554874 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 163768 | 21 |
1.015 | 54951 | 16 |
1.020 | 97859 | 21 |
1.025 | 46510 | 9 |
1.030 | 47075 | 8 |
Last trade - 11.28am 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online